[go: up one dir, main page]

TN2013000335A1 - Hepatitis c virus inhibitors - Google Patents

Hepatitis c virus inhibitors

Info

Publication number
TN2013000335A1
TN2013000335A1 TNP2013000335A TN2013000335A TN2013000335A1 TN 2013000335 A1 TN2013000335 A1 TN 2013000335A1 TN P2013000335 A TNP2013000335 A TN P2013000335A TN 2013000335 A TN2013000335 A TN 2013000335A TN 2013000335 A1 TN2013000335 A1 TN 2013000335A1
Authority
TN
Tunisia
Prior art keywords
hepatitis
compounds
virus inhibitors
virus
treatment
Prior art date
Application number
TNP2013000335A
Other languages
English (en)
Inventor
John A Bender
Omar D Lopez
Gan Wang
Makonen Belema
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/023595 external-priority patent/WO2012109080A1/fr
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of TN2013000335A1 publication Critical patent/TN2013000335A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TNP2013000335A 2011-03-25 2013-08-02 Hepatitis c virus inhibitors TN2013000335A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161467602P 2011-03-25 2011-03-25
PCT/US2012/023595 WO2012109080A1 (fr) 2011-02-07 2012-02-02 Inhibiteurs du virus de l'hépatite c

Publications (1)

Publication Number Publication Date
TN2013000335A1 true TN2013000335A1 (en) 2015-01-20

Family

ID=54337509

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000335A TN2013000335A1 (en) 2011-03-25 2013-08-02 Hepatitis c virus inhibitors

Country Status (1)

Country Link
TN (1) TN2013000335A1 (fr)

Similar Documents

Publication Publication Date Title
PH12013501543A1 (en) Hepatitis c virus inhibitors
MX2013001579A (es) Inhibidores del virus de la hepatitis c
MX2013001237A (es) Compuestos inhibidores del virus de la hepatitis c.
PH12020550552A1 (en) Inhibitors of hepatitis c virus
TN2012000264A1 (en) Hepatitis c virus inhibitors
TN2012000214A1 (en) Hepatitis c virus inhibitors
MX2011008045A (es) Inhibidores del virus de la hepatitis c.
MY152971A (en) Hepatitis c virus inhibitors
MX2010008749A (es) Inhibidores del virus de la hepatitis c.
PH12013502177A1 (en) Hepatitis c virus inhibitors
MX2010008531A (es) Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c.
MX2010008699A (es) Derivados heterociclicos como inhibidores de virus de la hepatitis c.
MX2012008221A (es) Inhibidores de virus flaviviridae.
MX2012008211A (es) Inhibidores de virus flaviviridae.
MX2012000959A (es) Inhibidores de los virus flaviviridae.
MX2013006475A (es) Inhibidores macrociclicos de virus flaviviridae.
PH12013502190A1 (en) Hepatitis c virus inhibitors
MX2013014002A (es) Inhibidores del virus de la hepatitis c.
PH12015500814A1 (en) Hepatitis c virus inhibitors
TN2013000335A1 (en) Hepatitis c virus inhibitors
TN2013000453A1 (en) Hepatitis c virus inhibitors
TH149188A (th) สารยับยั้งไวรัสตับอักเสบ c
MY163245A (en) Hepatitis c virus inhibitors